Document Detail

Inhaled Beta-2 Agonist Salbutamol for the Treatment of Transient Tachypnea of the Newborn.
MedLine Citation:
PMID:  21481414     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To evaluate the efficacy of inhaled salbutamol, a beta-2 adrenergic agonist, for the treatment of transient tachypnea of the newborn (TTN) and to determine whether inhaled salbutamol is safe in newborn infants. STUDY DESIGN: Inhaled salbutamol or normal saline solution was administered to 54 infants with gestational ages ranging from 34 to 39 weeks and TTN. The response to salbutamol therapy was evaluated by determining respiratory rate, clinical score of TTN, level of respiratory support, and fraction of inspired oxygen before and at 30 minutes and 1 and 4 hours after salbutamol nebulization. RESULTS: Among the 54 infants with TTN, 32 received salbutamol and 22 received normal saline solution. After one dose, the salbutamol group showed significant improvements in respiratory rate, clinical score of TTN, fraction of inspired oxygen, and level of respiratory support (P < .05). After treatment, the mean pH, partial pressure of arterial oxygen, and partial pressure of arterial carbon dioxide values were better in the salbutamol group when compared with the placebo group (P < .05). Duration of hospitalization in the neonatal intensive care unit was also shorter for the salbutamol group (P < .05). CONCLUSION: Inhaled salbutamol treatment was effective with respect to both clinical and laboratory findings of TTN and without adverse events.
Didem Armangil; Murat Yurdakök; Ayşe Korkmaz; Sule Yiğit; Gülsevin Tekinalp
Related Documents :
21376824 - Probiotics and neonatal necrotizing enterocolitis.
8035294 - Premature rupture of membranes in early pregnancy. neonatal prognosis.
21210254 - Role of hemocoagulase in pulmonary hemorrhage in preterm infants: a systematic review.
2299184 - Early-onset neonatal pneumococcal sepsis in siblings.
6699134 - Evolution of lactotropes in normal and anencephalic human fetuses.
20118944 - Neonatal respiratory failure due to a novel mutation in the surfactant protein c gene.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-8
Journal Detail:
Title:  The Journal of pediatrics     Volume:  -     ISSN:  1097-6833     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Mosby, Inc. All rights reserved.
Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of epithelial and fibroblastic cell behavior on nano/micro-topographic PCL membranes prod...
Next Document:  Natural history of hepatocellular adenoma formation in glycogen storage disease type I.